Thalita Alves Zanetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Thalita Alves Zanetti has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Amanda Cristina Corveloni
Londrina State Univ UEL, Ctr Biol Sci, Dept Gen Biol, Rodovia Celso Garcia Cid,Pr 445 Km 380, Londrina, Parana, Brazil
3 shared publicationsBruna Isabela Biazi
Londrina State Univ UEL, Ctr Biol Sci, Dept Gen Biol, Rodovia Celso Garcia Cid,Pr 445 Km 380, Londrina, Parana, Brazil
3 shared publicationsLilian Areal Marques
Department of General Biology, Center of Biological Sciences, Londrina State University – UEL, Londrina, Brazil
3 shared publicationsAdrivanio Baranoski
Londrina State Univ UEL, Ctr Biol Sci, Dept Gen Biol, Rodovia Celso Garcia Cid,Pr 445 Km 380, Londrina, Parana, Brazil
2 shared publicationsGiuliana Castello Coatti
Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA
2 shared publicationsMario Sergio Mantovani
Londrina State Univ UEL, Ctr Biol Sci, Dept Gen Biol, Rodovia Celso Garcia Cid,Pr 445 Km 380, Londrina, Parana, Brazil
2 shared publications
Latest Publications
- 14 December 2021
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 32 (5) , 341-351
Salinomycin induces cell cycle arrest and apoptosis and modulates hepatic cytochrome P450 mRNA expression in HepG2/C3a cells
Salinomycin (SAL) is a monocarboxylic polyether ionophore antibiotic isolated from Streptomyces albus. It exhibits an effective antitumor potential against numerous human cancer cells. This study aimed to assess the antiproliferative effects of SAL in human hepatocellular carcinoma HepG2/C3a cell line. We investigated the effects of SAL on cell growth, DNA damage induction, cell cycle changes and apoptosis; and relative changes in expression of cell cycle-related, apoptosis-related, and CYP450 genes. SAL induced cell cycle arrest in G2/M phase, upregulation of CDKN1A and GADD45A and downregulation of cyclin genes including CCNB1 and CCNA2. SAL effectively suppressed mRNA levels of CTNNB1 gene, an important oncogene that promotes tumorigenesis. The decrease of HepG2/C3A cells survival can also be due to downregulation of antiapoptotic BCL-2 expression, thus promoting the induction of apoptosis by SAL. This study also demonstrated the ability of SAL in modulating hepatic cytochrome P450 (CYP) mRNA expression, such that SAL caused the upregulation of CYP1A members and CYP3A5; and downregulation of CYP3A4. Taken together, these data contribute to the understanding of the mechanism of action of SAL, highlighting that metabolizing enzymes modulated by SAL can interfere with chemotherapy treatment and it must be considered in associated treatments. Graphical Abstract
- 14 December 2021
- Published by Taylor & Francis in Toxicology Mechanisms and Methods
- Vol. 32 (5) , 341-351
Salinomycin induces cell cycle arrest and apoptosis and modulates hepatic cytochrome P450 mRNA expression in HepG2/C3a cells
Salinomycin (SAL) is a monocarboxylic polyether ionophore antibiotic isolated from Streptomyces albus. It exhibits an effective antitumor potential against numerous human cancer cells. This study aimed to assess the antiproliferative effects of SAL in human hepatocellular carcinoma HepG2/C3a cell line. We investigated the effects of SAL on cell growth, DNA damage induction, cell cycle changes and apoptosis; and relative changes in expression of cell cycle-related, apoptosis-related, and CYP450 genes. SAL induced cell cycle arrest in G2/M phase, upregulation of CDKN1A and GADD45A and downregulation of cyclin genes including CCNB1 and CCNA2. SAL effectively suppressed mRNA levels of CTNNB1 gene, an important oncogene that promotes tumorigenesis. The decrease of HepG2/C3A cells survival can also be due to downregulation of antiapoptotic BCL-2 expression, thus promoting the induction of apoptosis by SAL. This study also demonstrated the ability of SAL in modulating hepatic cytochrome P450 (CYP) mRNA expression, such that SAL caused the upregulation of CYP1A members and CYP3A5; and downregulation of CYP3A4. Taken together, these data contribute to the understanding of the mechanism of action of SAL, highlighting that metabolizing enzymes modulated by SAL can interfere with chemotherapy treatment and it must be considered in associated treatments. Graphical Abstract
- 1 April 2021
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 338, 109410
Dimethoxycurcumin reduces proliferation and induces apoptosis in renal tumor cells more efficiently than demethoxycurcumin and curcumin
- 1 April 2021
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 338, 109410
Dimethoxycurcumin reduces proliferation and induces apoptosis in renal tumor cells more efficiently than demethoxycurcumin and curcumin
- 1 December 2019
- Published by Elsevier in Toxicology in Vitro
- Vol. 61, 104643
Mitotic spindle defects and DNA damage induced by dimethoxycurcumin lead to an intrinsic apoptosis pathway in HepG2/C3A cells
- 1 December 2019
- Published by Elsevier in Toxicology in Vitro
- Vol. 61, 104643
Mitotic spindle defects and DNA damage induced by dimethoxycurcumin lead to an intrinsic apoptosis pathway in HepG2/C3A cells
- 10 July 2018
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 50, 209-215
Response of HepG2/C3A cells supplemented with sodium selenite to hydrogen peroxide-induced oxidative stress
- 10 July 2018
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 50, 209-215
Response of HepG2/C3A cells supplemented with sodium selenite to hydrogen peroxide-induced oxidative stress